Japan Entry Acceleration Program: a launchpad towards the Japanese market for innovative health startups
The Japan Entry Acceleration Program 2025 (JEAP 2025) targets startups in regenerative medicine, cell and gene therapies, with a structured program running from September 2025 to March 2026. Five startups will be selected to benefit free of charge from personalized support, strategic networking, and a Demo Day in Tokyo. The application phase is open until […]
Firecell: Ultra-precise industrial 5G geolocation for Airbus
Firecell, project leader: Based in Nice, Firecell implemented the private 5G network, localization algorithms, and software infrastructure. Its central role achieved unprecedented precision of 1 to 5 meters in a dense industrial environment. A world first in aeronautics: At the Airbus site, the solution developed by Firecell, Orange, Miodex, and Desoutter demonstrated the ability to […]
Legal Design Agency chooses Nice Côte d’Azur
A pioneer of legal design on the French Riviera, Legal Design Agency — founded by Madina Ibrahimkhel (pictured) — transforms complex legal documents such as contracts, terms and conditions, GDPR/compliance policies, or shareholders’ agreements into clear, visual, and actionable tools for individuals, entrepreneurs (startups, SMEs/mid-caps), and legal departments. Its decision to set up in Nice […]
The Nice-based biotech Roca Therapeutics reaches a new milestone in its development
A European recognition for a neglected disease: Roca Therapeutics has obtained from the European Medicines Agency (EMA) the orphan drug designation for its drug candidate RCT002. This status marks the official recognition of radiation maculopathy as a disease in its own right, after having long been considered only a complication. This advancement enables reinforced regulatory […]
The South Region and HEC launch the ESS Sud Accelerator
The South Region has entrusted HEC Paris with the creation of an acceleration program dedicated to the social and solidarity economy (ESS). It is part of the regional strategy “My Business Project”. The program lasts 12 months and combines mentoring, HEC training, and networking. Ten organizations will be selected in autumn 2025. The model is […]
Cosma raises €2.5 million to map the seafloor on a large scale
Cosma, a startup from Nice specialized in seafloor mapping using autonomous drones and AI, has completed a €2.5 million fundraising round. The first drones produced in-house are currently being assembled; they enable the analysis of several square kilometers of seabed. The funding will be allocated to the production of its fleet of autonomous drones, to […]
Scale Up Excellence 2025: 8 Côte d’Azur winners join the national acceleration program
French Tech Côte d’Azur confirms its strategic role within the national Scale Up Excellence scheme. Of the more than 60 companies selected for the 2025 cohort, 8 come from the Côte d’Azur, demonstrating the strength of the local ecosystem in terms of innovation and growth. Among these 8 winners, 6 are based in the metropolitan […]
Team Nice Côte d’Azur at Viva Technology 2025: at the heart of technological transitions and international attractiveness
From June 11 to 14, 2025, Paris hosted Viva Technology, the largest European trade show dedicated to technological innovation. With more than 165,000 visitors, the event brought together startups, investors, public decision-makers and major companies around the technologies of tomorrow. The 2025 edition was particularly marked by international openness and major digital, ecological and industrial […]
Business Landing Nice Côte d’Azur: Support for business set up in France
Key elements of the Business Landing Nice Côte d’Azur scheme financial aid of up to €150,000 for SMEs and micro-enterprises wishing to establish themselves in Nice Côte d’Azur an economic ecosystem structured around strategic sectors personalised support from a strong local partnership network Find the access conditions for the scheme on the Nice Côte d’Azur […]
The Nice-based biotech company Roca Therapeutics receives financial support from Europe and the SUD region for its medical research in eye health
Major public funding for the Nice biotech: Roca Therapeutics receives over €1.1 million through the European program FEDER-FSE+-FTJ 2021–2027, co-funded by the European Union and the SUD Region. An innovative eye health project: RCT002 is an innovative non-invasive eye drop treatment for rare and debilitating ocular diseases such as radiation maculopathy and diabetic macular edema. […]
